{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:30:20Z","timestamp":1792301420886,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K16585"],"award-info":[{"award-number":["21K16585"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stevens\u2013Johnson syndrome and toxic epidermal necrolysis (SJS\/TEN) are potentially fatal medical conditions that lack established treatment. Therapeutic plasma exchange (PE) is a potential treatment option; however, its effectiveness is unclear. We aimed to evaluate the effectiveness of PE in patients with SJS\/TEN. A retrospective cohort study was conducted using data from the Japanese National Administrative Claims database from 2016 to 2021. The analysis included 256 patients diagnosed with SJS\/TEN who were admitted to the intensive care unit, of whom 38 received PE and 218 did not. The outcomes of patients who did and did not receive PE within the first 24\u00a0h of admission were compared. The risk ratios and 95% confidence intervals of the PE group compared with those of the no-PE group were as follows: in-hospital mortality, 0.983 (0.870\u20131.155); 30-day mortality rate, 1.057 (0.954\u20131.217); 50-day mortality rate, 1.023 (0.916\u20131.186); and length of hospital stay, 1.163 (0.762\u20131.365). This study does not provide evidence of a benefit of PE in reducing mortality or length of hospital stay in patients with severe SJS\/TEN.<\/jats:p>","DOI":"10.1038\/s41598-024-53653-5","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T05:02:20Z","timestamp":1707109340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness of early treatment with plasma exchange in patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis"],"prefix":"10.1038","volume":"14","author":[{"given":"Atsushi","family":"Senda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"key":"53653_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt, M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev. Clin. Immunol. 7, 803\u201313 (2011).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"53653_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0190-9622(91)70176-3","volume":"25","author":"R Avakian","year":"1991","unstructured":"Avakian, R., Flowers, F. P., Araujo, O. E. & Ramos-Caro, F. A. Toxic epidermal necrolysis: A review. J. Am. Acad. Dermatol. 25, 69\u201379 (1991).","journal-title":"J. Am. Acad. Dermatol."},{"key":"53653_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archderm.1984.01650420031010","volume":"120","author":"ED Westly","year":"1984","unstructured":"Westly, E. D. & Wechsler, H. L. Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator. Arch. Dermatol. 120, 721\u2013726 (1984).","journal-title":"Arch. Dermatol."},{"key":"53653_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/00015550510038232","volume":"85","author":"KJ Kim","year":"2005","unstructured":"Kim, K. J. et al. Toxic epidermal necrolysis: Analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients. Acta Derm. Venereol. 85, 497\u2013502 (2005).","journal-title":"Acta Derm. Venereol."},{"key":"53653_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jaad.2020.08.122","volume":"84","author":"TY Tsai","year":"2021","unstructured":"Tsai, T. Y. et al. Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis. J. Am. Acad. Dermatol. 84, 390\u2013397 (2021).","journal-title":"J. Am. Acad. Dermatol."},{"key":"53653_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann, S. et al. Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. JAMA Dermatol. 153, 514\u2013522 (2017).","journal-title":"JAMA Dermatol."},{"key":"53653_CR7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jid.2017.07.828","volume":"137","author":"JC Roujeau","year":"2017","unstructured":"Roujeau, J. C., Mockenhaupt, M., Guillaume, J. C. & Revuz, J. New evidence supporting cyclosporine efficacy in epidermal necrolysis. J. Invest. Dermatol. 137, 2047\u20132049 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"53653_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.anai.2022.05.009","volume":"129","author":"CC Tian","year":"2022","unstructured":"Tian, C. C. et al. Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann. Allergy Asthma Immunol. 129, 360-365.e1 (2022).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"53653_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0190-9622(99)70497-4","volume":"40","author":"CA Egan","year":"1999","unstructured":"Egan, C. A., Grant, W. J., Morris, S. E., Saffle, J. R. & Zone, J. J. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J. Am. Acad. Dermatol. 40, 458\u2013461 (1999).","journal-title":"J. Am. Acad. Dermatol."},{"key":"53653_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1046\/j.1365-4362.1997.00192.x","volume":"36","author":"GC Chaidemenos","year":"1997","unstructured":"Chaidemenos, G. C. et al. Plasmapheresis in toxic epidermal necrolysis. Int. J. Dermatol. 36, 218\u2013221 (1997).","journal-title":"Int. J. Dermatol."},{"key":"53653_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","volume":"6","author":"G Bamichas","year":"2002","unstructured":"Bamichas, G. et al. Plasma exchange in patients with toxic epidermal necrolysis. Ther. Apher. 6, 225\u2013228 (2002).","journal-title":"Ther. Apher."},{"key":"53653_CR12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s001340051063","volume":"25","author":"A Furubacke","year":"1999","unstructured":"Furubacke, A., Berlin, G., Anderson, C. & Sj\u00f6berg, F. Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?. Intensive Care Med. 25, 1307\u20131310 (1999).","journal-title":"Intensive Care Med."},{"key":"53653_CR13","first-page":"19","volume":"7","author":"H Yasunaga","year":"2015","unstructured":"Yasunaga, H., Matsui, H., Horiguchi, H., Fushimi, K. & Matsuda, S. Clinical epidemiology and health services research using the Diagnosis Procedure Combination Database in Japan. Asian Pac. J. Dis. Manag. 7, 19\u201324 (2015).","journal-title":"Asian Pac. J. Dis. Manag."},{"key":"53653_CR14","first-page":"110","volume":"59","author":"KB Ishikawa","year":"2016","unstructured":"Ishikawa, K. B. Medical big data for research use: Current status and related issues. Jpn. Med. Assoc. J. 59, 110\u2013124 (2016).","journal-title":"Jpn. Med. Assoc. J."},{"key":"53653_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40257-019-00443-9","volume":"20","author":"K Morita","year":"2019","unstructured":"Morita, K., Matsui, H., Michihata, N., Fushimi, K. & Yasunaga, H. Association of early systemic corticosteroid therapy with mortality in patients with Stevens-Johnson syndrome or toxic epidermal necrolysis: A retrospective cohort study using a nationwide claims database. Am. J. Clin. Dermatol. 20, 579\u2013592 (2019).","journal-title":"Am. J. Clin. Dermatol."},{"key":"53653_CR16","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/aje\/kwq439","volume":"173","author":"MJ Funk","year":"2011","unstructured":"Funk, M. J. et al. Doubly robust estimation of causal effects. Am. J. Epidemiol. 173, 761\u2013767 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"53653_CR17","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/aje\/kwab041","volume":"190","author":"T St\u00fcrmer","year":"2021","unstructured":"St\u00fcrmer, T. et al. Propensity score weighting and trimming strategies for reducing variance and bias of treatment effect estimates: A simulation study. Am. J. Epidemiol. 190, 1659\u20131670 (2021).","journal-title":"Am. J. Epidemiol."},{"key":"53653_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018174","volume":"6","author":"BK Lee","year":"2011","unstructured":"Lee, B. K., Lessler, J. & Stuart, E. A. Weight trimming and propensity score weighting. PLoS ONE 6, e18174 (2011).","journal-title":"PLoS ONE"},{"key":"53653_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamadermatol.2023.0035","volume":"159","author":"Y Miyamoto","year":"2023","unstructured":"Miyamoto, Y. et al. Evaluation of plasmapheresis vs immunoglobulin as first treatment after ineffective systemic corticosteroid therapy for patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. JAMA Dermatol. 159, 481\u2013487 (2023).","journal-title":"JAMA Dermatol."},{"key":"53653_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1744-9987.2008.00609.x","volume":"12","author":"H Yamada","year":"2008","unstructured":"Yamada, H. & Takamori, K. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan. Ther. Apher. Dial. 12, 355\u2013359 (2008).","journal-title":"Ther. Apher. Dial."},{"key":"53653_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bjps.2004.12.007","volume":"58","author":"M Lissia","year":"2005","unstructured":"Lissia, M., Figus, A. & Rubino, C. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: Preliminary report. Br. J. Plast. Surg. 58, 504\u2013510 (2005).","journal-title":"Br. J. Plast. Surg."},{"key":"53653_CR22","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","volume":"66","author":"A Downey","year":"2012","unstructured":"Downey, A., Jackson, C., Harun, N. & Cooper, A. Toxic epidermal necrolysis: Review of pathogenesis and management. J. Am. Acad. Dermatol. 66, 995\u20131003 (2012).","journal-title":"J. Am. Acad. Dermatol."},{"key":"53653_CR23","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1001\/archderm.1985.01660120074023","volume":"121","author":"D Kamanabroo","year":"1985","unstructured":"Kamanabroo, D., Schmitz-Landgraf, W. & Czarnetzki, B. M. Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch. Dermatol. 121, 1548\u20131549 (1985).","journal-title":"Arch. Dermatol."},{"key":"53653_CR24","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1001\/jama.1980.03310210025020","volume":"244","author":"EJ Wing","year":"1980","unstructured":"Wing, E. J., Bruns, F. J., Fraley, D. S., Segel, D. P. & Adler, S. Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 244, 2423\u20132426 (1980).","journal-title":"JAMA"},{"key":"53653_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","volume":"27","author":"H Yamana","year":"2017","unstructured":"Yamana, H. et al. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J. Epidemiol. 27, 476\u2013482 (2017).","journal-title":"J. Epidemiol."},{"key":"53653_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin, S. et al. SCORTEN: A severity-of-illness score for toxic epidermal necrolysis. J. Invest. Dermatol. 115, 149\u2013153 (2000).","journal-title":"J. Invest. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53653-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53653-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53653-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T09:07:47Z","timestamp":1707383267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53653-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53653"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-53653-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2893"}}